Antiplatelet agents: effects on the progressive renal disease
Zoja, C.; Perico, N.; Remuzzi, G.
American Journal of Kidney Diseases the Official Journal of the National Kidney Foundation 17(5 Suppl 1: 98-102
1991
ISSN/ISBN: 0272-6386 PMID: 2024685 Document Number: 383631
Document emailed within 1 workday
Related Documents
Kasiske, B.L.; Lakatua, J.D. 1997: The effects of dietary protein restriction on chronic progressive renal disease Mineral and Electrolyte Metabolism 23(3-6): 296-300Wang, Y.-m.; Cao, Y.-j.; Liu, C.-f.; Feng, P. 2007: The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction Zhonghua Nei Ke Za Zhi 46(7): 562-565
Hostetter, J.C.; Bhatt, D.L. 2003: The expanding role of antiplatelet agents in coronary artery disease. a current review of aspirin, glycoprotein IIb/IIIa inhibitors, and the thienopyridines Minerva Cardioangiologica 51(5): 531-546
Zavalska, T.V. 2014: Antiplatelet Therapy Influence on Immunological Status of Progressive Angina Patients Likars'ka Sprava 2014(9-10): 43-46
Anderson, S.; Brenner, B.M. 1989: Progressive renal disease: a disorder of adaptation Quarterly Journal of Medicine 70(263): 185-189
Benigni, A.; Remuzzi, G. 1995: Endothelin in the progressive renal disease of glomerulopathies Mineral and Electrolyte Metabolism 21(4-5): 283-291
Dunn, B.R.; Anderson, S.; Brenner, B.M. 1986: The hemodynamic basis of progressive renal disease Seminars in Nephrology 6(2): 122-138
Gomes, O.M. 1982: Antiplatelet agents: how much? which one? for whom? Arquivos Brasileiros de Cardiologia 38(1): 1-2
Anderson, S. 1988: Systemic and glomerular hypertension in progressive renal disease Kidney International. Suppl 25: S119-S121
Agodoa, L.; Eknoyan, G.; Ingelfinger, J.; Keane, W.; Mauer, M.; Mitch, W.; Striker, G.; Wilcox, C. 1997: Assessment of structure and function in progressive renal disease Kidney International. Suppl 63: S144-S150
Ishikawa, K. 2003: Anticoagulant, antiplatelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 647-653
Coccheri, S. 2013: New antiplatelet agents: are we better off now than we were with aspirin? Clinical Advances in Hematology and Oncology: H&o 11(12): 787-790
De Caterina, R.; Blanco, A. 1992: Nitrates as antiplatelet agents Sangre 37(1): 31-38
Cappelli, P.; Di Liberato, L.; Stuard, S.; Ballone, E.; Albertazzi, A. 1997: N-3 polyunsaturated fatty acid supplementation in chronic progressive renal disease Journal of Nephrology 10(3): 157-162
De Gautard, G.; Perrier, A. 2014: Antiplatelet agents in secondary prevention of stroke Revue Medicale Suisse 10(446): 1902 1904-7
Bochenek, A.; Wilczyński, M.ła. 2006: Antiplatelet agents--problem for cardiac surgeon Kardiologia Polska 64(11): 1329-1331
Griguer, R.P.; Brochier, M.; Raynaud, R. 1973: The place of fibrinolytic and antiplatelet-aggregation agents in therapy Annales de Cardiologie et d'Angeiologie 22(6): 461-472
Hegge, K.A. 2009: Antiplatelet agents for prevention of recurrent ischemic stroke South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(1): 15-17
Satoh, S. 2011: Usage of antiplatelet and anticoagulant agents in ischemic cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 423-427
Teng, C.M.; Ko, F.N.; Wang, J.P.; Lin, C.N.; Wu, T.S.; Chen, C.C.; Huang, T.F. 1991: Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs Journal of Pharmacy and Pharmacology 43(9): 667-669